|[May 01, 2014]
Research and Markets: Global Biochips and Microarrays 2014-218: Technologies, Markets and Companies - Updated 2014 Report
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/k3vt7x/biochips_and)
has announced the addition of Jain PharmaBiotech's new report "Biochips
and Microarrays - Technologies, Markets and Companies" to their
The report provides current share of each segment: market size in 2012
and projected value for the years 2018 and 2023. Gene expression has the
largest share and is an established market. Share of microarray
technologies in other areas will grow with the maximum growth in RNA
splice variants followed by epigenetics. The growth in protein
microarrays is somewhat less, partly because it is more mature than the
other submarkets and has already shown considerable growth in the past.
Impact of next generation sequencing on segmentsof microarray markets
is identified. Customer requirements and unmet needs are described.
Markets are also analyzed according to geographical areas.
This report is an analysis of biochip/microarray markets based on
technologies and applications. The report starts with a description of
technologies as a basis for estimation of markets. Technologies include
array comparative genomic hybridization (CGH), copy number variation
(CNV), DNA methylation, ChIP-Chip, RNA splice variants, and microRNA.
Separate chapters are devoted to protein biochips/microarrays,
microfluidics and nanobiotechnology-based nano-arrays.
Various applications of biochips and microarrays are described
throughout the report. Areas of application such as point-of-care,
genetic screening, cancer, and diagnosis of infections are included.
Separate chapters are devoted to applications in drug discovery and
development as well as personalized medicine
Key Topics Covered:
0. Executive Summary
1. Introduction to Virology
2. Antiviral Approaches
3. Vaccines for Virus Infections
4. Role of Nanotechnology in Developing Antiviral Agents
5. Delivery of Antivirals
6. Competitive Assessment of Antiviral Approaches
7. Influenza Viruses
9. Hepatitis Viruses
10. Miscellaneous Commercially Important Virus Infections
11. Viruses with High Impact but Low Commercial Significance
12. Markets for Antivirals
For more information visit http://www.researchandmarkets.com/research/k3vt7x/biochips_and
Source (News - Alert): Jain PharmaBiotech
[ InfoTech Spotlight's Homepage ]